Clinical Trials
3 trialsNCT02973763 2025-04-03
Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer
Allist Pharmaceuticals, Inc.
Phase 1 Terminated
NCT03127449 2025-04-03
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Allist Pharmaceuticals, Inc.
Phase NA Terminated
NCT03452592 2025-04-03
Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M
Allist Pharmaceuticals, Inc.
Phase 2 Terminated